Health

FDA Approves First Device for Treating Children with ADHD

The first medical device to treat children with attention deficit /Hyperactivity Disability (ADHD) Approved by the US Food and Drug Administration.

This device sends low levels of electrical pulses to the relevant areas of the brain Symptoms of ADHD Approved for the treatment of children aged 7-12 years who are not taking the drug ADHD, CNN report.

Treatment with the NeuroSigma Monarch External Trigeminal Nerve Stimulation System (eTNS) is prescription and caregiver..

“This new device offers safe non-drug options for treatment ADHD In pediatric patients, this type of first mild neurostimulation is used. “

The pocket-sized device is for home use while the child is sleeping. It is wired to a small patch placed on the child’s forehead on the eyebrows, CNN report.

In a clinical trial of 62 children, children using the device showed a statistically significant improvement. Symptoms of ADHD, According to the FDA, compared to those who received placebo.

According to the NeuroSigma website, the device is currently not covered by insurance and the starter kit can cost just over $ 1,000. CNN report.

Copyright © 2019 Health Day. all rights reserved.




Slide show

ADHD symptoms in children
Watch slideshow



FDA Approves First Device for Treating Children with ADHD

Source link FDA Approves First Device for Treating Children with ADHD

Back to top button